| Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study NA Kennedy, GA Heap, HD Green, B Hamilton, C Bewshea, GJ Walker, ... The lancet Gastroenterology & hepatology 4 (5), 341-353, 2019 | 560 | 2019 |
| Association of genetic variants in NUDT15 with thiopurine-induced myelosuppression in patients with inflammatory bowel disease GJ Walker, JW Harrison, GA Heap, MD Voskuil, V Andersen, ... Jama 321 (8), 773-785, 2019 | 135 | 2019 |
| Exclusive enteral nutrition provides an effective bridge to safer interval elective surgery for adults with Crohn's disease N Heerasing, B Thompson, P Hendy, GA Heap, G Walker, R Bethune, ... Alimentary pharmacology & therapeutics 45 (5), 660-669, 2017 | 126 | 2017 |
| Faecal calprotectin effectively excludes inflammatory bowel disease in 789 symptomatic young adults with/without alarm symptoms: a prospective UK primary care cohort study GJ Walker, L Moore, N Heerasing, P Hendy, MH Perry, TJ McDonald, ... Alimentary Pharmacology & Therapeutics 47 (8), 1103-1116, 2018 | 41 | 2018 |
| Quality improvement project identifies factors associated with delay in IBD diagnosis GJ Walker, S Lin, N Chanchlani, A Thomas, P Hendy, N Heerasing, ... Alimentary Pharmacology & Therapeutics 52 (3), 471-480, 2020 | 25 | 2020 |
| Incidence and prevalence of inflammatory bowel disease in Devon, UK B Hamilton, H Green, N Heerasing, P Hendy, L Moore, N Chanchlani, ... Frontline Gastroenterology 12 (6), 461-470, 2021 | 24 | 2021 |
| OTU-002 HLA-DQA1 contributes to the development of antibodies to anti-TNF therapy in Crohn’s disease A Sazonovs, NA Kennedy, C Bewshea, L Moutsianas, GJ Walker, ... Gut 67 (Suppl 1), A52-A53, 2018 | 7 | 2018 |
| OP031 Clinical effectiveness, safety and immunogenicity of anti-TNF therapy in Crohn’s disease: 12-month data from the PANTS study NA Kennedy, G Heap, B Hamilton, GJ Walker, C Bewshea, S Bouri, ... Journal of Crohn's and Colitis 12 (supplement_1), S021-S021, 2018 | 6 | 2018 |
| Sexual enquiry in older people J Warner, E Starren, G Walker British Journal of General Practice 58 (547), 125-126, 2008 | 6 | 2008 |
| 159-Clinical effectiveness, safety and immunogenicity of anti-TNF therapy in Crohn's disease: 12 month data from the Pants study NA Kennedy, GA Heap, B Hamilton, GJ Walker, CM Bewshea, S Bouri, ... Gastroenterology 154 (6), S-44, 2018 | 5 | 2018 |
| Drug toxicity: personalising IBD therapeutics–the use of genetic biomarkers to reduce drug toxicity G Walker, T Ahmad Biomarkers in Inflammatory Bowel Diseases, 257-269, 2019 | 4 | 2019 |
| PTU-010 prevalence and phenotype of IBD across primary and secondary care: implications for colorectal cancer surveillance B Hamilton, N Heerasing, PJ Hendy, L Moore, GJ Walker, C Bewshea, ... Gut 67 (Suppl 1), A67-A67, 2018 | 4 | 2018 |
| Mixed fortunes in the treatment of Crohn's disease G Walker, P Venkatachalam, J Bird, D Wilson, C Probert The Lancet 379 (9832), 2212, 2012 | 1 | 2012 |
| Sexual activity and experience of management of sexual difficulties in older people with mental illness G Walker, E Starren, J Warner International Psychogeriatrics 17, 140-140, 2005 | 1 | 2005 |
| Drug Toxicity: Personalising IBD G Walker, T Ahmad Biomarkers in Inflammatory Bowel Diseases, 257, 2019 | | 2019 |
| Precision Medicine in Inflammatory Bowel Disease G Walker PQDT-UK & Ireland, 2019 | | 2019 |
| Su1875-Prevalence and Phenotype of Inflammatory Bowel Disease Across Primary and Secondary Care: Implications for Colorectal Cancer Surveillance N Heerasing, PJ Hendy, L Moore, GJ Walker, CM Bewshea, T Ahmad, ... Gastroenterology 154 (6), S-615-S-616, 2018 | | 2018 |
| OTU-021 EFFECT OF THE TWO-WEEK WAIT REFERRAL PATHWAY ON COLORECTAL CANCER DETECTION: SYSTEMATIC REVIEW AND META-ANALYSIS H Green, B Hamilton, G Walker, J Goodhand, N Kennedy Gut 10, A1-A284, 2018 | | 2018 |
| Pain, pus, and paralysis T Robinson, G Walker, P Davison, S Croxson Practical Diabetes International 27 (6), 228-228, 2010 | | 2010 |
